Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial)

Karow, Anne; Reimer, Jens; König, Hans Helmut; Heider, Dirk; Bock, Thomas; Huber, Christian; Schöttle, Daniel; Meister, Klara; Rietschel, Liz; Ohm, Gunda; Schulz, Holger; Naber, Dieter; Schimmelmann, Benno G; Lambert, Martin (2012). Cost-effectiveness of 12-month therapeutic assertive community treatment as part of integrated care versus standard care in patients with schizophrenia treated with quetiapine immediate release (ACCESS trial). Journal of clinical psychiatry, 73(3), e402-8. Memphis, Tenn.: Physicians Postgraduate Press

Full text not available from this repository. (Request a copy)

To compare the 1-year cost-effectiveness of therapeutic assertive community treatment (ACT) with standard care in schizophrenia. ACT was specifically developed for patients with schizophrenia, delivered by psychosis experts highly trained in respective psychotherapies, and embedded into an integrated care system.

Item Type:

Journal Article (Original Article)

Division/Institute:

04 Faculty of Medicine > University Psychiatric Services > University Hospital of Child and Adolescent Psychiatry and Psychotherapy

UniBE Contributor:

Schimmelmann, Benno Karl Edgar

ISSN:

0160-6689

Publisher:

Physicians Postgraduate Press

Language:

English

Submitter:

Myriam Pyrlik

Date Deposited:

04 Oct 2013 14:36

Last Modified:

17 Mar 2015 21:27

PubMed ID:

22490266

URI:

https://boris.unibe.ch/id/eprint/14643 (FactScience: 221716)

Actions (login required)

Edit item Edit item
Provide Feedback